期刊文献+

炎症性肠病与肠道菌群 被引量:8

原文传递
导出
摘要 肠道菌群是居住在人和动物胃肠道的一个特殊生态系统,其种类繁多,数量巨大。肠道的微生物数量是人体细胞数量的10倍,构成了人类的“第二基因组”,并作为共生生态系统影响人类的健康、营养及生长发育。近年来,随着研究技术的进步,对人类肠道微生态的研究及其对健康与疾病影响的研究呈现空前的增长。目前的问题是,消化道常见疾病患者肠道菌群的变化如何?肠道菌群调节人体功能的具体机制是什么?
作者 谭蓓 钱家鸣
出处 《中华内科杂志》 CAS CSCD 北大核心 2015年第5期399-402,共4页 Chinese Journal of Internal Medicine
  • 相关文献

参考文献28

  • 1Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing [ J ]. Nature, 2010, 464 (7285) :59-65.
  • 2Walker AW, Sanderson JD, Churcher C, et al. High-throughput clone library analysis of the mueosa-associated mierobiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease [ J ]. BMC Microbiol, 2011, 11:7.
  • 3Martinez C, Antolin M, Santos J, et al. Unstable composition of the fecal microbiota in ulcerative colitis during clinical remission [ J ]. Am J Gastroenterol, 2008, 103 ( 3 ) :643-648.
  • 4MeLaughlin SD, Walker AW, Chureher C, et al. The bacteriology of pouchitis : a molecular phylogenetic analysis using 16S rRNA gene cloning and sequencing[ J]. Ann Surg, 2010, 252 ( 1 ) :90-98.
  • 5Willing BP, Dicksved J, Halfvarson J, et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes[ J]. Gastroenterology, 2010, 139(6) :1844-1854.
  • 6Joossens M, Huys G, Cnockaert M, et al. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives[ J]. Gut, 2011, 60(5 ) :631-637.
  • 7Madsen KL, Malfair D, Gray D, et al. Interleukin-10 gene- deficient mice develop a primary intestinal permeability defect in response to enteric microflora [ J ]. Inflamm Bowel Dis, 1999, 5 (4) :262-270.
  • 8Hugot JP, Cbamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease [ J ]. Nature, 2001,411 (6837) :5994503.
  • 9Duchmann R, Kaiser I, Hermann E, et al. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD) [ J]. C lin Exp Immunol, 1995, 102 ( 3 ) :448-455.
  • 10Ohkusa T, Kato K, Terao S, et al. Newly developed antibiotie combination therapy for ulcerative colitis: a double-blind placebo- controlled muhieenter trial [ J ]. Am J Gastroenterol, 2010, 105 (8) :1820-1829.

同被引文献66

引证文献8

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部